Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Dotarem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/03/2026 GE Healthcare Inc
    United Kingdom
    		 GE Healthcare AS Korea Branch 20210611-211-J-1026 Gadoterate meglumine solution 2021-06-11 GE Healthcare AS, Lindesnes Site Norway Lindesnesveien 208, Lindesnes, NO-4521, Norway
    31/03/2026 Hainan Poly Pharm
    China
    		 Pharmapia Co., Ltd. 20250430-210-J-1890 Gadoterate meglumine 2025-04-30 Anhui Poly Pharm Co., Ltd China No.58 Xiahong Road,High-tech Industrial Development Zone,Anqin City,Anhui Province
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.